DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis-Reference-Cited by-同舟云学术

DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis

Published:2022-03 Issue:2 Volume:114 Page:110289
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

Noor Humaira,Whittaker Shane,McDonald Kerrie L.

Publisher

Elsevier BV

Subject

Genetics

Reference72 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016;Ostrom;Neuro-Oncology,2019

2. Management for different glioma subtypes: are all low-grade gliomas created equal?;Tom;Am. Soc. Clin. Oncol. Educ. Book,2019

3. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016

4. The correlation between 1p/19q Codeletion, IDH1 mutation, p53 overexpression and their prognostic roles in 41 Turkish anaplastic Oligodendroglioma patients;Hacisalihoglu;Turk Neurosurg.,2017

5. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide;Speirs;Int. J. Radiat. Oncol. Biol. Phys.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies;Signal Transduction and Targeted Therapy;2024-05-27

2. The Role of Antibody-Based Therapies in Neuro-Oncology;Antibodies;2023-11-13

3. Impact of epigenetic reprogramming on antitumor immune responses in glioma;Journal of Clinical Investigation;2023-01-17

4. Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance;Cancer Drug Resistance;2022